Instant Access with secure payment processing: $235 / One Month $975 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Patent Expiration - 2011

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Type Patent Number Patent Expiration Patented / Exclusive Use Pharmacia And Upjohn AROMASIN exemestane 020753 Oct 21, 1999 RX 4,808,616 Apr 1, 2011 TREATMENT OF ADVANCED HORMONE-DEPENDENT BREAST CANCER Astrazeneca ATACAND candesartan cilexetil 020838 Jun 4, 1998 RX 5,705,517 Apr 18, 2011 TREATMENT OF HYPERTENSION AND TREATMENT OF HEART FAILURE Astrazeneca ATACAND HCT candesartan cilexetil; hydrochlorothiazide 021093 May 16, 2008 RX 5,705,517 Apr 18, 2011 TREATMENT OF HYPERTENSION Astrazeneca ATACAND HCT candesartan cilexetil; hydrochlorothiazide 021093 Sep 5, 2000 RX 5,705,517 Apr 18, 2011 TREATMENT OF HYPERTENSION Lantheus Medcl DEFINITY perflutren 021064 Jul 31, 2001 RX 5,547,656 Apr 5, 2011

 Complete access available with subscription